Publication:
Does Three Cycle Chemotherapy Affect Liver, Spleen and Bone Marrow Glycolytic Activity in Non-Hodgkin Lymphoma Patients?

dc.contributor.authorsAras, M.; Dede, F.; Ones, T.; Candemir, S.; Inanir, S.; Erdil, T. Y.; Turoglu, H. T.
dc.date.accessioned2022-03-10T17:50:31Z
dc.date.accessioned2026-01-11T18:18:40Z
dc.date.available2022-03-10T17:50:31Z
dc.date.issued2011
dc.identifier.doidoiWOS:000208619401481
dc.identifier.issn1619-7070
dc.identifier.urihttps://hdl.handle.net/11424/221351
dc.identifier.wosWOS:000208619401481
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDoes Three Cycle Chemotherapy Affect Liver, Spleen and Bone Marrow Glycolytic Activity in Non-Hodgkin Lymphoma Patients?
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS375
oaire.citation.startPageS375
oaire.citation.titleEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
oaire.citation.volume38

Files